GHK-Cu vs AHK-Cu: One Residue Apart, Two Separate Research Literatures

These two copper-binding tripeptides differ at one position only — glycine in one, alanine in the other — yet that single substitution sends their published literatures in opposite directions. The better-documented of the pair is GHK-Cu, the copper(II) complex of Gly-His-Lys (CAS 89030-95-5, 403.93 g/mol), which underpins most published work on matrix biology and skin models. AHK-Cu (Ala-His-Lys; CAS 1245800-58-7; roughly 417.96 g/mol as the complex; INCI name copper tripeptide-3) appears almost exclusively in hair-follicle and dermal-papilla studies. Choosing between GHK-Cu with AHK-Cu is therefore not a potency question but a question of which research tradition your experiment is meant to continue.

Both are offered as freeze-dried blue powder with a certificate for each lot: GHK-Cu in 200 mg, 100 mg and 50 mg vials, and AHK-Cu in 100 mg and 50 mg vials. The copper peptides collection shows the family they belong to, and neither product is a therapeutic — both are research chemicals.

One methyl group, two separate literatures

From a chemical standpoint there is very little between them. In each tripeptide the imidazole ring of histidine together with the free N-terminal amine provides the principal coordination set for copper(II), and the resulting complex is blue — copper binding you can see without instrumentation. Replacing glycine with alanine adds a methyl group at residue one: too small to disturb the copper geometry, but enough to change hydrophobicity, how the molecule behaves at interfaces in a formulation and, in principle, how a receptor or transporter reads the N-terminal end.

What matters far more than chemistry is provenance. Work on humans beginning in the 1970s established GHK as an endogenous plasma tripeptide whose sequence occurs in collagen alpha-2(I), which explains why its literature is rooted in matrix biology. AHK has no such endogenous story — it was designed as an analogue of GHK and reached the literature via cosmetic science and follicle research. For any protocol that requires a molecule with a documented physiological counterpart, that imbalance settles the matter. Background on the class is in the glossary entry copper peptide, with a fuller treatment at What is GHK-Cu?.

Research to date

GHK-Cu in matrix, wound-healing and skin research

Most of the GHK-Cu literature is preclinical and covers a lot of ground. In fibroblast systems, papers report increased output of collagen, elastin, decorin and glycosaminoglycans, alongside altered levels of matrix metalloproteinases and their tissue inhibitors — a remodelling profile rather than a single molecular target. Wound studies in rabbits and rodents from the 1980s onwards described faster closure and different granulation tissue where copper tripeptide was applied compared with vehicle alone. Transcriptome surveys have reported effects on a very large number of transcripts in cultured cells, which is why review articles usually describe GHK as a matrix signalling molecule rather than an agonist at a receptor. What human data exist come predominantly from cosmetic products: controlled facial studies of creams containing GHK reported measurable changes in roughness and density measures — appearance endpoints for finished cosmetics, and not claims about research-grade powder.

AHK-Cu in hair-follicle and papilla models

The literature on AHK-Cu covers far less ground. Experiments using cultured human hair follicles report greater elongation and a prolonged growth phase relative to control medium, and studies on dermal papilla cells report increased proliferation together with raised VEGF expression. The authors read these results as angiogenic and papilla-supporting signalling within the follicle. The evidence is thinner, the model systems more specialised, and independent replication limited — points any protocol relying on this work should acknowledge plainly. See What is AHK-Cu? for our fuller treatment, and Peptides for Hair Growth: Research Overview for the wider field.

The problem they share

Both molecules are studied as vehicles for copper, and the recurring methodological trap is distinguishing signalling attributable to the peptide from the simple consequence of making copper available. Copper on its own changes lysyl oxidase activity and influences a number of redox-dependent pathways. Any credible comparison therefore runs a copper-salt arm and a copper-free peptide arm as well; lacking those, a positive finding cannot be assigned to the tripeptide rather than to its metal cargo. That is equally true of both compounds and is the single most common weakness in copper-peptide work.

Choosing between them

• If your endpoints are collagen, elastin or other extracellular-matrix measures in fibroblast or dermal systems, GHK-Cu is the obvious choice — the comparison literature and the assay conventions already exist. Start with GHK-Cu vials.
• If you are measuring follicle elongation in organ culture, papilla-cell proliferation or angiogenic readouts in the follicle, use AHK-Cu vials: that is the compound the published follicle studies used, so your data stay comparable with theirs.
• If you are comparing the two analogues directly, equalise molarity rather than mass — 14 g/mol is a modest difference, but the free peptide and the complex do not weigh the same. See the molecular weight and molarity guide for the arithmetic.
• If the subject is topical formulation science, both are relevant, and the ready-made GHK-Cu + AHK-Cu Hair Serum is there for stability work on a finished format rather than for raw peptide chemistry.
• If you are screening several peptides in follicle models, the Hair Growth Stack pairs the two copper tripeptides with PTD-DBM.

Handling, stability and storage

Practically speaking, both are handled the same way, and one shared caution matters more than any difference: the active entity is the copper complex, and a strongly acidic environment can pull it apart. If a solution stops being blue, that is information about its integrity. Each peptide goes into solution readily in sterile or bacteriostatic water. Store the lyophilised material sealed at −20 °C away from light and humidity; keep reconstituted stock at 2-8 °C in the dark and use it within the study window. Since repeated freezing and thawing of aqueous stock is the usual reason potency drifts without explanation, aliquot at the first reconstitution as a matter of routine. How to Store Peptides and the reconstitution guide give the practical detail.

For topical research there is one further formulation caveat: copper tripeptides do not tolerate several widely used cosmetic actives — concentrated acids and strong reducing agents in particular — and combining them in a single vehicle can pull the copper off the peptide before it ever reaches the test system. Topical Peptides in Cosmetic Research covers formulation questions in more depth.

What to verify on the certificate

For copper peptides, a purity number on its own falls short. Look for mass-spectrometric confirmation of the peptide's identity, an HPLC purity value for the peptide component, and where possible a copper content figure or the stoichiometry of the complex — because material that is nominally pure as a tripeptide but only partially complexed behaves differently in any assay sensitive to copper. Both of our products ship at ≥99% HPLC purity with a lot-specific certificate, and How to Read a Peptide COA explains how to interpret the document. Since consistency between lots matters most in longitudinal work, keep lot numbers alongside your data.

Summary for protocol selection

GHK-Cu remains the reference compound of this class: more literature behind it, a known endogenous counterpart, and default status in matrix and skin research. AHK-Cu is the narrower analogue whose value lies specifically in extending the follicle literature. For neighbouring comparisons and family context, see the hair research peptides collection and the skin research overview.